Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia

Circulation

Volumn 122, Issue 11 SUPPL. 1, 2010, Pages

  Robich, Michael P ^a,b   Osipov, Robert M ^b   Nezafat, Reza ^b   Feng, Jun ^c   Clements, Richard T ^c   Bianchi, Cesario ^c   Boodhwani, Munir ^d   Coady, Michael A ^c   Laham, Roger J ^b   Sellke, Frank W ^a,b  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

angiogenesis; coronary disease; hypercholesterolemia; ischemia; perfusion

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; RESVERATROL; SUBSTANCE P; VASCULOTROPIN; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE; VASCULOTROPIN A;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE BLOOD FLOW; ANGIOGENESIS; ANIMAL; CAPILLARY; CHRONIC DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY DISEASE; DISEASE MODEL; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEART MUSCLE; HUMAN; MALE; METABOLISM; MICROCIRCULATION; MORTALITY; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PERFUSION; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPILLARIES; CHRONIC DISEASE; CORONARY CIRCULATION; CORONARY DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PERFUSION; SIGNAL TRANSDUCTION; STILBENES; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957240051     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.920132     Document Type: Article

References (24)

1. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
2. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J. Sirt1 regulates aging and resistance to oxi-dative stress in the heart. Circ Res. 2007;100:1512-1521.
3. Boodhwani M, Nakai Y, Mieno S, Voisine P, Bianchi C, Araujo EG, Feng J, Michael K, Li J, Sellke FW. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg. 2006;81: 634-641.
4. Lavu S, Boss O, Elliott PJ, Lambert PD. Sirtuins: novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov. 2008;7: 841-853.
5. Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer. 2009;9:123-128.
6. Pillarisetti S. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov. 2008;3: 156-164.
7. Stef G, Csiszar A, Lerea K, Ungvari Z, Veress G. Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J Cardiovasc Pharmacol. 2006;48:1-5.
8. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba MO. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science. 2005;310:314-317.
9. Ryf S, Kissinger KV, Spiegel MA, Bornert P, Manning WJ, Boesiger P, Stuber M. Spiral MR myocardial tagging. Magn Reson Med. 2004;51: 237-242.
10. Haber I, Metaxas DN, Axel L. Three-dimensional motion reconstruction and analysis of the right ventricle using tagged MRI. Med Image Anal. 2000;4:335-355.
11. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986;74:469-476.
12. Tofukuji M, Metais C, Li J, Franklin A, Simons M, Sellke FW. Myo-cardial VEGF expression after cardiopulmonary bypass and cardioplegia. Circulation. 1998;98:II242-II248.
13. Boodhwani M, Voisine P, Ruel M, Sodha NR, Feng J, Xu SH, Bianchi C, Sellke FW. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction. Eur J Cardiothorac Surg. 2008;33:645-652.
14. Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, Clements RT, Sellke FW. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007;116:I31-I37.
15. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci\USA. 2007;104:14855-14860.
16. Li HF, Tian ZF, Qiu XQ, Wu JX, Zhang P, Jia ZJ. A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery. Physiol Res. 2006;55:365-372.
17. Kaga S, Zhan L, Matsumoto M, Maulik N. Resveratrol enhances neovas-cularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol. 2005;39:813-822.
18. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, Zeiher AM, Dimmeler S. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007;21:2644-2658.
19. Sodha NR, Clements RT, Boodhwani M, Xu SH, Laham RJ, Bianchi C, Sellke FW. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol. 2009; 296:H428-H434.
20. Boodhwani M, Mieno S, Voisine P, Feng J, Sodha N, Li J, Sellke FW. High-dose atorvastatin is associated with impaired myocardial angio-genesis in response to vascular endothelial growth factor in hypercholes-terolemic swine. J Thorac Cardiovasc Surg. 2006;132:1299-1306.
21. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette L, Hemmings BA, Kass DA, Champion HC, Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest. 2005;115:2128-2138.
22. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyo-cardial infarction remodeling. Circ Res. 2004;94:1543-1553.
23. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32:1377-1382.
24. Elliott PJ, Jirousek M. Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs. 2008;9:371-378.